DG
14
6
EBAY
42
2
SWK
53
4
MAC
53
5
GS
65
16
IP
53
3
TRV
34
4
ICE
53
5
GIS
47
13
MO
47
6
CF
47
5
AFL
34
6
SJM
17
5
JNJ
30
4
CVS
27
2
MA
60
5
MAT
41
2
ES
12
3
CLX
65
2
NVDA
52
5
DG
14
6
EBAY
42
2
SWK
53
4
MAC
53
5
GS
65
16
IP
53
3
TRV
34
4
ICE
53
5
GIS
47
13
MO
47
6
CF
47
5
AFL
34
6
SJM
17
5
JNJ
30
4
CVS
27
2
MA
60
5
MAT
41
2
ES
12
3
CLX
65
2
NVDA
52
5
Financhill
Back

Astrana Health Quote, Financials, Valuation and Earnings

The AI Energy Miracle

Details Here.
Sell
32

ASTH
Astrana Health

Last Price:
$33.5200
Seasonality Move:
25.1%

7 Day Trial

ALL ACCESS PASS

$ 7

Trump's Legacy-Defining Momentor Strike

But the Surprising Way Trump Solves it Could Cement His Legacy.

Astrana Health Price Quote

$33.5200
-0.1800 (-4.47%)
(Updated: December 22, 2024 at 12:48 AM ET)

Astrana Health Key Stats

Sell
32
Astrana Health (ASTH) is a Sell
Day range:
$33.4400 - $35.9300
52-week range:
$33.4400 - $63.2000
Dividend yield:
0%
P/E ratio:
26.12
P/S ratio:
0.93
P/B ratio:
2.18%
Volume:
964.4K
Avg. volume:
359.7K
1-year change:
-6.7%
Market cap:
$1.5B
Revenue:
$1.4B
EPS:
$1.3

How Much Does Astrana Health Make?

Data Unavailable

Is Astrana Health Growing As A Company?

Data Unavailable

Astrana Health Stock Price Performance

  • Did Astrana Health Stock Go Up Last Month?
    Astrana Health share price went down by -17.89% last month
  • Did ASTH's Share Price Rise Over The Last Year?
    ASTH share price fell by -6.7% over the past 1 year

What Is Astrana Health 52-Week High & Low?

Astrana Health Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Astrana Health?

Data Unavailable

Is Astrana Health Cash Flow Positive?

Data Unavailable

Astrana Health Return On Invested Capital

Data Unavailable

Astrana Health Earnings Date & Stock Price

Astrana Health Competitors

  • Who Are Astrana Health's Competitors?
    Below is a list of companies who compete with Astrana Health or are related in some way:
    • American Shared Hospital Services (AMS)
    • Biote Corp (BTMD)
    • Cryo-Cell International Inc (CCEL)
    • Evolent Health Inc (EVH)
    • P3 Health Partners Inc (PIII)

Astrana Health Dividend Yield

Data Unavailable

Astrana Health Analyst Estimates

YoY Growth Past Surprise
EPS: -29.79% 9.82%
Revenue: 37.49% 3.53%

Analyst Recommendations

Buy Recommendations: 10
Hold Recommendations: 2
Sell Recommendations: 0
Price Target: 64.5000
Upside from Last Price: 91.39%

Major Shareholders

Data Unavailable